0 Bedömningar

ID

27988

Beskrivning

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Nyckelord

  1. 2017-12-07 2017-12-07 -
  2. 2018-01-02 2018-01-02 -
Rättsinnehavare

Prof. Dr. med. Georg Heß

Uppladdad den

7 december 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Concomitant Medication GOAL Trial B-cell Lymphoma NCT02499003

    Concomitant Medication GOAL Trial B-cell Lymphoma NCT02499003

    Admininstrative data
    Beskrivning

    Admininstrative data

    Subject ID
    Beskrivning

    Subject ID

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Are there any relevant concomitant medications (incl. all transfusion packs)?
    Beskrivning

    relevant concomitant medications

    Datatyp

    boolean

    Concomitant Medication
    Beskrivning

    Concomitant Medication

    No.
    Beskrivning

    medication number

    Datatyp

    integer

    Medication
    Beskrivning

    Medication

    Datatyp

    text

    Indication
    Beskrivning

    Indication

    Datatyp

    text

    Dose Unit [e .g. 10, as needed]
    Beskrivning

    Dose Unit

    Datatyp

    text

    Dose form
    Beskrivning

    Dose form

    Datatyp

    integer

    Start date
    Beskrivning

    Start date

    Datatyp

    date

    Stop date
    Beskrivning

    Stop date

    Datatyp

    date

    Ongoing at End of Treatment?
    Beskrivning

    Ongoing medication at End of Treatment

    Datatyp

    boolean

    Similar models

    Concomitant Medication GOAL Trial B-cell Lymphoma NCT02499003

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Admininstrative data
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    relevant concomitant medications
    Item
    Are there any relevant concomitant medications (incl. all transfusion packs)?
    boolean
    Item Group
    Concomitant Medication
    medication number
    Item
    No.
    integer
    Medication
    Item
    Medication
    text
    Indication
    Item
    Indication
    text
    Dose Unit
    Item
    Dose Unit [e .g. 10, as needed]
    text
    Item
    Dose form
    integer
    Code List
    Dose form
    CL Item
    Tablet (0)
    CL Item
    Film-coated tablet (1)
    CL Item
    Chewable tablet (2)
    CL Item
    Throat lozenge (3)
    CL Item
    Capsule (4)
    CL Item
    Dragee (5)
    CL Item
    Powder (6)
    CL Item
    Granulate (7)
    CL Item
    Salve (8)
    CL Item
    Cream (9)
    CL Item
    Drop (10)
    CL Item
    Spray (11)
    CL Item
    Solution (12)
    CL Item
    Injection (13)
    CL Item
    Infusion (14)
    CL Item
    Adhesive Bandage (15)
    CL Item
    Juice (16)
    CL Item
    Sachets (17)
    CL Item
    Gel (18)
    CL Item
    Suppository (19)
    CL Item
    Carbon tablets (20)
    CL Item
    Inhalant (21)
    Start date
    Item
    Start date
    date
    Stop date
    Item
    Stop date
    date
    Ongoing medication at End of Treatment
    Item
    Ongoing at End of Treatment?
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial